Lessons for lupus from tumour necrosis factor blockade. - Wikidata - wikimedia - TriplyDB

Lessons for lupus from tumour necrosis factor blockade.

Lessons for lupus from tumour necrosis factor blockade.

http://www.wikidata.org/entity/Q36677012

about

Lupus: an overview of the disease and management options.Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α.Integrated analysis of mRNA, microRNA and protein in systemic lupus erythematosus-specific induced pluripotent stem cells from urine Immunotherapy of autoimmunity and cancer: the penalty for success.Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE).Drug-induced lupus erythematosus: incidence, management and prevention.TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy.Antinuclear antibody (ANA) testing in patients treated with biological DMARDs: is it useful?Infliximab-Induced Lupus: A Case Report.Anti-NuMA antibodies in a psoriatic patient: Considerations about clinical relevance and effect of infliximab treatment

P2860

Q34638296-6A8503B5-A37C-4F09-A581-AA37A4814FDC Q35808834-A827F323-C6AF-4EA2-8F8C-1D562D20C716 Q36073380-58ABE34C-C7E1-4D1B-A507-2D2B16E4068A Q37325451-66157091-BCC4-47A8-BAE4-9838FC330D57 Q37406698-F1A87F5E-BF3E-4A46-901E-C058C036B3DC Q37709460-99523DAB-93DE-4F51-9307-63630D0A5AE5 Q37868002-465748A3-11BD-49A8-A52D-3E28F9FF88A9 Q38125529-3D828D9C-7F7B-4195-959B-75D08C4462BB Q38179468-14BD9414-FB99-4CEC-AEB7-9B26397A4315 Q38411852-A9591609-E041-4425-A94B-8C8AE1D22E30 Q55019792-3D44B635-2532-4CEB-8F5F-5D671BDDF04F Q58986153-9750F23B-2798-4240-BE5B-6A667EADDFAF

P2860

Lessons for lupus from tumour necrosis factor blockade.

http://www.wikidata.org/entity/Q36677012

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Lessons for lupus from tumour necrosis factor blockade.

@ast

Lessons for lupus from tumour necrosis factor blockade.

@en

type

label

Lessons for lupus from tumour necrosis factor blockade.

@ast

Lessons for lupus from tumour necrosis factor blockade.

@en

prefLabel

Lessons for lupus from tumour necrosis factor blockade.

@ast

Lessons for lupus from tumour necrosis factor blockade.

@en

P1433

Q36677012-BD7EAFE4-B3C0-48F3-AF5E-50A25A4439AD

P1476

Q36677012-E8B8D797-1AE6-45E0-A157-8CF2FF7921F3

P2093

Q36677012-9356CD6D-1962-42AA-8EE6-EE902CD30CF6

P2860

Q36677012-12973E87-05A3-4279-9B5E-0D73CA8CFC32

Q36677012-1A58FE56-2A73-4817-BA4F-91C085E45CD0

Q36677012-1C26DF43-FCC1-42E2-A983-9D4F7D2EC8EE

Q36677012-1E686BDE-E805-4F7A-BDD7-9F6FC41C81F7

Q36677012-25E70F04-C009-4F62-BA1A-C2D414122BCB

Q36677012-2D55BC6D-E452-44B7-BAEF-D4CF7851018A

Q36677012-34D1122E-C92D-478D-9A47-DA73757B86EA

Q36677012-38341C56-7C96-4779-80D3-219D41608146

Q36677012-47B5A176-B2C0-450E-9D1A-F21EB0FED7A1

Q36677012-4F80FBC2-0933-4F28-9890-E94DFB00C121

P304

Q36677012-A7574983-40E9-47D8-B758-37F6108F193F

P31

Q36677012-226EA3F8-EDF3-46EF-A1F9-A2EFDE45C114

P356

Q36677012-CF05E3F3-0CCC-49CD-8C91-3F610D51F5B4

P433

Q36677012-80D6D8D6-0C7D-46A4-98FC-A8C12770B4EF

P478

Q36677012-FCC7322B-D7E5-4FEB-9FF0-2E46BFC9763B

P577

Q36677012-10EAC527-4B4D-4332-9D16-CA8222FC4F16

P698

Q36677012-0AF792EB-D525-4C55-9334-CD29A4F25A3E

P921

Q36677012-c5daec3c-2a48-4a6f-be77-612ccdbdbedb

P356

0961203306071703

P1433

P1476

Lessons for lupus from tumour necrosis factor blockade.

@en

P2093

M De Bandt

http://www.w3.org/2001/XMLSchema#string

P2860

Cross-regulation of TNF and IFN-alpha in autoimmune diseases

Systemic lupus erythematosus and the type I interferon system

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

The key role of nucleosomes in lupus.

Apoptosis: definition, mechanisms, and relevance to disease.

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.

P304

762-767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203306071703

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17153848

http://www.w3.org/2001/XMLSchema#string

P921